![Matthew Notarianni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Notarianni
Investor Relations Kontakt bei
MIMEDX GROUP, INC.
Profil
Matthew Notarianni is currently Head-Investor Relations at MiMedx Group, Inc. since 2022.
Formerly, Mr. Notarianni was Senior Director-Investor Relations at Cerus Corp.
Mr. Notarianni completed undergraduate studies at Marquette University.
Aktive Positionen von Matthew Notarianni
| Unternehmen | Position | Beginn |
|---|---|---|
| MIMEDX GROUP, INC. | Investor Relations Kontakt | 04.10.2022 |
Ehemalige bekannte Positionen von Matthew Notarianni
| Unternehmen | Position | Ende |
|---|---|---|
| CERUS CORPORATION | Investor Relations Kontakt | - |
Ausbildung von Matthew Notarianni
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Marquette University
 Marquette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
